Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT03084939 · COMPLETED
Trial details
- NCT number
- NCT03084939
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2018-11-23
- Enrollment
- 351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.